MedPath

A clinical trial to study the effect of adding dexmedetomidine to ropivacaine scalp block to attenuate the hemodynamic response to skull pin placement in neurosurgical procedures

Phase 1
Conditions
Health Condition 1: - Health Condition 2: C71- Malignant neoplasm of brain
Registration Number
CTRI/2019/08/020826
Lead Sponsor
Department Of Anesthesiology and Critical Care
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex

Patients aged 18 to 65 years

American Society of Anesthesiologists physical status grade I and II

Patients scheduled for elective neurosurgical procedures under general anesthesia with tracheal intubation

Exclusion Criteria

Patients with uncontrolled hypertension

Patients with preoperative bradycardia, ischemic heart disease, cardiac arrhythmias

Patients with severe hepatic and renal disease

Patients with past history of craniotomy

Patients allergic to study drugs

Patients on alpha blockers treatment preoperatively

Patient refusal

Patient unable to give consent

Pregnant women and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate , systolic blood pressure , diastolic blood pressure and mean arterial pressure are measured at different time points following skull pin placement .Timepoint: Heart rate , systolic blood pressure , diastolic blood pressure and mean arterial pressure are measured at 1 3 5 10 minutes following skull pin placement
Secondary Outcome Measures
NameTimeMethod
2.Number of episodes of hypertension, hypotension, bradycardia and tachycardiaTimepoint: during study period.
© Copyright 2025. All Rights Reserved by MedPath